Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PBMs’ Impact On Drug Prices Probed By House Committee Leaders

Sep 04 2018

• By Cathy Kelly

Pros and cons concept. Business man with cardboard plus and minus symbol signs.

Related Content

Drug Pricing: US House, Senate, Taking Bicameral Go-Slow Approach

Dec 13 2017

Medicare Part D Plans Can Start Negotiating Indication-Based Pricing This Fall

Aug 31 2018

Drug Firms Fear PBM ‘Discrimination’ Over List Price Reductions, Azar Tells Hearing

Jun 12 2018

HHS Advancing Attack On Rebates With Proposal To Revoke Safe Harbor

Jul 25 2018

Pharma’s Blame-The-Middleman Strategy Pays Off – For Now

May 16 2018

Related Companies

Express Scripts Holding Company

CVS Health Corp.

UnitedHealth Group

Humana Inc.

Additional Topics

United States Legislation Pricing Debate Policy BioPharmaceutical

More from Legislation

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window